Attachments
Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.
Journal/
conference: JAMA Network Open
conference: JAMA Network Open
Research:Paper
Organisation/s:
University of Navarra, Spain
Funder:
This study was supported by grant FI19/00236 from the Instituto de Salud Carlos III (Dr
Aguilera-Buenosvinos) and PhD studentship in Molecular, Genetic and Lifecourse Epidemiology grant 224982/Z/
22/Z from theWellcome Trust (Ms Morales Berstein). The coordination of the European Prospective Investigation
Into Cancer and Nutrition (EPIC) study is financially supported by the International Agency for Research on Cancer
(IARC) and the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London,
which has additional infrastructure support provided by the National Institute for Health Research Imperial
Biomedical Research Centre. The national cohorts are supported by the Danish Cancer Society (Denmark); Ligue
Contre le Cancer, Institut Gustave Roussy, Mutuelle Générale de l’Education Nationale, and Institut National de la
Santé et de la Recherche Médicale (France); German Cancer Aid, German Cancer Research Centre, German
Institute of Human Nutrition Potsdam-Rehbruecke, and Federal Ministry of Education and Research (Germany);
Associazione Italiana per la Ricerca sul Cancro, Compagnia di SanPaolo, and National Research Council (Italy);
Dutch Ministry of Public Health,Welfare and Sports, Netherlands Cancer Registry, LK Research Funds, Dutch
Prevention Funds, Zorg Onderzoek Nederland,World Cancer Research Fund, and Statistics Netherlands (the
Netherlands); Health Research Fund–Instituto de Salud Carlos III, regional governments of Andalucía, Asturias,
Basque Country, Murcia, and Navarra, and the Catalan Institute of Oncology (Spain); Swedish Cancer Society,
Swedish Research Council, and County Councils of Skåne and Västerbotten (Sweden); grants 14136 to EPIC-Norfolk
and C8221/A29017 to EPIC-Oxford from Cancer Research UK, and grants 1000143 to EPIC-Norfolk and
MR/M012190/1 to EPIC-Oxford from the Medical Research Council (UK).